Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 5Breast 3Tumor-Agnostic 2Gynecologic 2Genitourinary 2CNS 2Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Gastrointestinal 1Dermatologic 1

Conditions

Glioma 2Sleep Initiation and Maintenance Disorders 1Oligodendroglioma 1Nervous System Diseases 1Neoplasms 1Meningioma 1Lymphoma 1Glioblastoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 165Magnetic Resonance Spectroscopy 130Radiotherapy 95Specimen Handling 80Radiosurgery 60Cyclophosphamide 55pembrolizumab 51Bevacizumab 51Nivolumab 48Radiation 47Carboplatin 34Biopsy 33Irinotecan 29Lomustine 25Etoposide 25Vincristine 23Topotecan 23Ipilimumab 23dinutuximab 21Cisplatin 21Blood Specimen Collection 21fludarabine 19Radiotherapy, Intensity-Modulated 19X-Rays 18Surgical Procedures, Operative 18abemaciclib 16Mental Status and Dementia Tests 16Granulocyte-Macrophage Colony-Stimulating Factor 16Pemetrexed 15atezolizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cognitive Behavioral Therapy × CNS × 1 year × Clear all
NCT06468176 2025-12-19

FREEDOME

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
187 enrolled
CNS

Glioma, Neoplasms, Nervous System Diseases

NCT06439420 2025-10-01

CBT-I in PBT

Virginia Commonwealth University

Phase 2 Completed
70 enrolled
CNSLymphoid

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Sleep Initiation and Maintenance Disorders, Lymphoma, Meningioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡